XIGDUO 5 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 60 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400927886768 -
CIP7
2788676 -
CIS
60267506 -
Registration number
EU/1/13/900
What the source publishes
- Holder
- ASTRAZENECA AB
- Active ingredients
- CHLORHYDRATE DE METFORMINE, DAPAGLIFLOZINE PROPANEDIOL MONOHYDRATÉ, DAPAGLIFLOZINE
- Form
- comprimé pelliculé
- Package
- plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 60 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2014-01-16
- Prescription
- Prescription or restricted
Names this record is found by
- XIGDUO 5 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 60 comprimé(s)
- XIGDUO 5 mg/1000 mg, comprimé pelliculé
- CHLORHYDRATE DE METFORMINE
- DAPAGLIFLOZINE PROPANEDIOL MONOHYDRATÉ
- DAPAGLIFLOZINE
Complete source data
{
"cis": "60267506",
"cip7": "2788676",
"form": "comprimé pelliculé",
"name": "XIGDUO 5 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 60 comprimé(s)",
"cip13": "3400927886768",
"holder": "ASTRAZENECA AB",
"routes": [
"orale"
],
"holders": [
"ASTRAZENECA AB"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "37.59",
"authorisedOn": "2014-01-16",
"compositions": [
{
"name": "CHLORHYDRATE DE METFORMINE",
"nature": "SA",
"strength": "1000 mg",
"linkageNumber": "2",
"substanceCode": "24321",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "DAPAGLIFLOZINE PROPANEDIOL MONOHYDRATÉ",
"nature": "SA",
"strength": "6,15 mg",
"linkageNumber": "1",
"substanceCode": "41338",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "DAPAGLIFLOZINE",
"nature": "FT",
"strength": "5 mg",
"linkageNumber": "1",
"substanceCode": "50433",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "36.57",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "XIGDUO 5 mg/1000 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 60 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2020-04-06",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE DE METFORMINE",
"DAPAGLIFLOZINE PROPANEDIOL MONOHYDRATÉ",
"DAPAGLIFLOZINE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Diabète dit \"de type 2\" : si un traitement de ce diabète n'a pas donné satisfaction en utilisant de la metformine seule, ou de la metformine associée à un sulfamide hypoglycémiant, ou de la metformine associée à de l'insuline ou encore pour remplacer un traitement qui associait séparément les deux principes actifs qui constituent ce médicament. ; JOURNAL OFFICIEL ; 01/04/20",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/13/900",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400927886768"